It’s not all bad… we have multiple NDA’s. I didn’t
It’s not all bad… we have multiple NDA’s. I didn’t want to believe that but Dr. Kelly stated that. It looks like they have broke down the ability of partnering by the indication and that is the future. Even breaking down HIV into multiple partnerships. Ie. Combo, Mono, Prep and maybe even cure. Is this because they are locked into a partnership in Combo that has only performance reasons to break that partnership in HIV Combo? Can’t even talk buy-out because of our first partnership?
I have to say that the immense future possibilities being cut in half if we can negotiate a 50/50 deal on any indication like we did with HIV Combo could be still lucrative. Our future indications that we can partner with isn’t the best direction forward I had hoped for. Not all is lost with partners if it helps us move the timing and speed of indications foreword on different levels and speed of developing investments by individual indications. There has to be a benefit to move quickly like partnering on a few indications in what seems like a very rushed way.
I still hope that we partner only a few indications and hopefully keep some indications for ourselves when we do achieve revenue or large pre payments for any of the partnerships. My hope is still alive that we can grow ourselves into a pharmaceutical company.
It’s all in how you word our individual partnership contracts and if our current management sees a future that’s worth growing or is looking to just get out of the biotech world the easy way in selling all indications quickly and throwing in the towel on growth of becoming a pharmaceutical company. Having multiple NDA’s is a direction that says individual indications have been separated and we will negotiate the best deals possible both here and internationally. It leaves hope for us and is encouraging to see the separation of indications and not just a roll over and you win… buy-out… of Cytodyns potential. It gives us the potential to see large value still to be realized. So let’s hope we negotiate with a future eye looking to a bright future as a pharmaceutical company. Because when you run the numbers… being our own pharmaceutical company is where the money and return on our investment is best realized.
10
CytoDyn Inc (CYDY) Stock Research Links
Scroll down for more posts ▼
Top 10 Most Recent News Articles
Monster Energy's Skateboard Triumph Hold the front page, because Monster Energy just pulled off a clean sweep in Paris. The company's team riders dominated the Men's Skateboard Street competition at the SLS Paris 2026, with the iconic Nyjah Huston snagging the top spot. It's a story filled with triumph, grit, and a dash of raw talent in a vibrant field of international...
Continue Reading
ARTBOX: From Seoul to La-La Land Here's what caught my eye. It's 2026, and Korean lifestyle retailer ARTBOX is making a splash in the U.S.—kicking things off with a pop-up in LA. Now, usually, I'd be skeptical about pop-ups, but you've got to admire the audacity and timing here. They've picked Melrose Avenue, a hotspot for all things trendy, to introduce their mix of...
Continue Reading
A Grand Stage for New Arrivals Picture this: In the bustling and glittering chaos that was the Wonder Festival Shanghai 2026, held from October 3 to 4, Blokees laid down a major marker. More than 500 products, an artillery of imagination and craftsmanship, were on deck across their key lines—Blokees Model Kits and BLOKEES WHEELS. With 90 brand-new creations making their...
Continue Reading
Examining the Intricacies of Pending M&A The merger and acquisition landscape can be vicious, especially when the sharks—those pesky class action lawyers—start circling. And let me tell you, Monteverde & Associates PC is diving headfirst into the fray, launching inquiries into a handful of these deals. This isn't your first stroll down Wall Street if you’ve seen one...
Continue Reading
Setting the Pace in Waste Management If there's one thing that sticks in my craw, it's how businesses handle food waste. Power Knot Middle East (PKME) seems to have cracked the code by not just leading the charge in organic waste management but also bagging THE BIZZ 2026 award. They’re not just playing industry games; PKME's pulling the strings with real leadership and...
Continue Reading
Shaking Up Diabetes Care: New Tech Unveiled Imagine a world where managing diabetes isn't a juggling act with multiple devices. That's precisely the future SiBionics and PharmaSens are pitching at the European Association for the Study of Diabetes (EASD) 2026 in Milan. Now, let me tell you, these guys aren't just playing around with ideas; they're aiming to radically...
Continue Reading
A Plastic-Laden Piece of History Makes Art Who'd have thought a plastic-covered couch would turn into a cultural artifact? This iconic staple in Black households has done just that, debuting at Brooklyn's CultureCon in a fresh guise. It's more than just an upcycled furniture piece; it's a living archive that encapsulates Black culture, joy, and resilience. The Heart...
Continue Reading
Seeking Justice Amid Heartbreak Tragedy rarely arrives whispered on the wind—more often, it's the train wreck some saw coming long before it hits. The tragic death of Jenna Menias, a 6-year-old from Frankfort, Illinois, falls squarely in this camp. The family's legal lions, Corboy & Demetrio, have slapped two school districts—District 210 and 157-C—with a wrongful...
Continue Reading
Diving Into M&A Deals Under Monteverde's Lens Wall Street’s not just about suits and skyscrapers; it’s about the nitty-gritty of deals and whether those numbers add up in the investor's favor. So, when Monteverde & Associates PC throws its weight into scrutinizing mergers and acquisitions, you better believe it's worth a second look. See, they’re digging into four...
Continue Reading
Unpacking Monteverde's M&A Investigations Hold your horses, folks! The M&A Class Action Firm is stirring the pot with its latest inquiries into some high-profile mergers. We're looking at Lisata Therapeutics, Flag Ship Acquisition Corporation, Baldwin Insurance Group, and ACV Auctions. So what's got Juan Monteverde's legal eagles swooping in on these deals? Well, are we...
Continue Reading
Top 5 Most Recently Viewed Articles
Unveiling Solana Accelerate at Consensus Hong Kong In the dynamic world of digital assets, significant collaborations shape the future, and the partnership between CoinDesk and the Solana Foundation exemplifies this. Together, they are bringing Solana Accelerate to Consensus Hong Kong, a premier event in the crypto landscape aimed at uniting innovators and...
Continue Reading
Municipality Finance Issues a New EUR 20 Million Tranche Municipality Finance Plc has recently taken a significant step by issuing a new tranche worth EUR 20 million under its Medium Term Note (MTN) programme. This strategic move follows the earlier issuance of notes on a recent date, bringing the total nominal amount of the notes to a noteworthy EUR 40 million. The...
Continue Reading
iRhythm Technologies Achieves Significant Milestone iRhythm Technologies, Inc. saw its stock rise dramatically in pre-market trading, experiencing an impressive increase of 20.5%, bringing shares to $74.80. This surge followed the company's exciting announcement regarding FDA clearance for its 510(k) submission. This achievement is tied to previous design changes made to...
Continue Reading
Carrot Fertility, Inc. just made waves on February 18, 2026, by rolling out a new parenting benefit—on-demand pediatric telemedicine through a partnership with Blueberry Pediatrics. But before you get swept up in the feel-good story of working parents finally getting support for sick kids, let’s dissect this offering and the numbers behind it. Telemedicine Tactics:...
Continue Reading
Freename Unveils the Innovative .etherlink Domain Freename, a prominent player in the multi-chain Web3 namespace sector, has recently announced an exciting development with the integration of Etherlink, a Layer 2 blockchain solution built on Tezos Smart Rollups. This partnership culminated in the unveiling of the new top-level domain, .etherlink. This initiative...
Continue Reading